ZoBio

Leiden, Netherlands Founded: 2004 • Age: 22 yrs Acquired By Oncodesign Services
Provider of fragment-based drug discovery services

About ZoBio

ZoBio is a company based in Leiden (Netherlands) founded in 2004 was acquired by Oncodesign Services in January 2024.. ZoBio offers products and services including Drug Discovery Services and Biophysical Assays. ZoBio operates in a competitive market with competitors including Slingshot Bioscience, StemoniX, Magnitude Biosciences, InterAx Biotech and Signal Pharmaceuticals, among others.

  • Headquarter Leiden, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zobio Bv
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $277.64 K (USD), Grant

    Mar 01, 2016

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Oncodesign Services

    (Jan 23, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ZoBio

ZoBio offers a comprehensive portfolio of products and services, including Drug Discovery Services and Biophysical Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Comprehensive services for identifying molecules in drug development

Tools for biochemical analysis in protein-based drug discovery

Funding Insights of ZoBio

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $277,643
  • First Round

    (01 Mar 2016)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2016 Amount Grant - ZoBio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ZoBio

ZoBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Oncodesign Services. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
CRO focused on oncology drugs discovery, bioanalysis, and preclinical services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ZoBio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ZoBio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zobio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ZoBio

ZoBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slingshot Bioscience, StemoniX, Magnitude Biosciences, InterAx Biotech and Signal Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Next-generation synthetic cells are developed for diagnostics and therapeutics.
domain founded_year HQ Location
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
domain founded_year HQ Location
Cell-free in vitro assays are supplied to drug discovery firms.
domain founded_year HQ Location
Mutated arrestins are employed as biosensors for GPCR drug discovery.
domain founded_year HQ Location
Small molecule drugs regulating disease-associated genes are developed.
domain founded_year HQ Location
Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about ZoBio

When was ZoBio founded?

ZoBio was founded in 2004 and raised its 1st funding round 12 years after it was founded.

Where is ZoBio located?

ZoBio is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.

What does ZoBio do?

ZoBio offers fragment-based drug discovery services for the pharmaceutical and biotechnology industries. They have developed a proprietary Target Immobilized NMR Screening (TINS) technology. They have also developed drug discovery platforms offering protein production, HIT discovery, and structural biology.

Who are the top competitors of ZoBio?

ZoBio's top competitors include Magnitude Biosciences, Slingshot Bioscience and StemoniX.

What products or services does ZoBio offer?

ZoBio offers Drug Discovery Services and Biophysical Assays.

Who are ZoBio's investors?

ZoBio has 2 investors. Key investors include European Union, and Oncodesign Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available